This website is developed by bluebird bio, Inc. and is intended for US residents 18 years of age and older only. View HCP Site

Prescribing Information
Patient Information
Important Safety Information

Find a Qualified Treatment Center

How ZYNTEGLO Works
Clinical Results
Safety & Side Effects
Treatment Journey
Support
FAQs

You have been unsubscribed

Unsubscribe successful.

We’re sorry to see you go. If you did this by mistake, or change your mind,
please feel free to sign up again.

Go to Homepage

Important Safety Information

What is the most important information I should know about ZYNTEGLO?

The most common side effects of ZYNTEGLO are:

On the day of treatment with ZYNTEGLO

Increased heart rate
Abdominal pain

Following treatment for up to 6 months

Low level of platelets, which may reduce the ability of blood to clot and may cause bleeding
Low level of white blood cells, which may make you more susceptible to infection
Pain in arms or legs

Call your healthcare provider right away if you have new or unusual bleeding which may include any of these signs or symptoms:

Severe headache
Abnormal bruising
Nose bleed
Blood in your urine, stool, or vomit
Coughing up blood
Unusual stomach or back pain

You may experience side effects associated with other medicines administered as part of the ZYNTEGLO treatment regimen. Talk to your physician regarding those possible side effects. Your healthcare providers may give you other medicines to treat your side effects.

It is important for you to be monitored at least yearly for at least 15 years for any changes to your blood. There is a potential risk of blood cancer associated with this treatment; however, no cases have been seen in studies of ZYNTEGLO. If you are diagnosed with a cancer, have your treating physician contact bluebird bio at 1-833-999-6378.

How will I get ZYNTEGLO?

Your healthcare providers will give you other medicines, including chemotherapy medicine, as part of your treatment with ZYNTEGLO. It’s important to talk to your healthcare provider about the risks and benefits of all medicines involved in your treatment.

After receiving the chemotherapy it may not be possible for you to become pregnant or father a child. You should consider discussing options for fertility preservation with your doctor before treatment.

STEP 1: ZYNTEGLO is made specifically for you from your own blood stem cells. Your healthcare provider will collect your blood stem cells through a process called mobilization and apheresis. This process takes approximately one week and may need to be repeated.

‘Back-up’ stem cells (or ‘rescue cells’) are also collected and stored at the hospital. This is a precaution in case there is a problem in the treatment process. If this happens, your back-up stem cells will be given back to you. If you receive back-up cells, you will have no benefit from ZYNTEGLO.

STEP 2: Your blood stem cells will be sent to a manufacturing site where they are used to make ZYNTEGLO. It takes approximately 70–90 days from the time your cells are collected to manufacture and test ZYNTEGLO before it is shipped to your healthcare provider, but the time may vary.

STEP 3: Before you receive ZYNTEGLO, your healthcare provider will give you chemotherapy for a few days to make room in the bone marrow. You will be admitted to the hospital for this step and remain in the hospital until after ZYNTEGLO infusion.

STEP 4: ZYNTEGLO is given by an intravenous infusion. You may receive more than one bag of ZYNTEGLO. Each bag is infused in 30 minutes or less.

After ZYNTEGLO infusion, you will stay in the hospital for approximately 3-6 weeks so that your healthcare team can closely monitor your recovery. Your healthcare provider will determine when you can go home.

What should I avoid after receiving ZYNTEGLO?

Do not donate blood, organs, tissues or cells.

What are additional possible or reasonably likely side effects of ZYNTEGLO?

ZYNTEGLO will not give you human immunodeficiency virus (HIV) infection. Treatment with ZYNTEGLO may cause a false-positive HIV test result by some commercial tests. If you need a HIV test, talk with your healthcare provider about the appropriate test to use.

These are not all the possible side effects of ZYNTEGLO. Call your doctor for medical advice about side effects. You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1-800-FDA-1088.

General Information

It is important that you have regular check-ups with your healthcare provider, including at least annual blood tests, to detect any adverse effects and to confirm that ZYNTEGLO is still working. Talk to your healthcare provider about any concerns.

Please see full Prescribing Information and Patient Information for ZYNTEGLO.

What is ZYNTEGLO?

ZYNTEGLO is a one-time gene therapy to treat beta-thalassemia (also known as beta-thalassemia major or Cooley’s Anemia) in patients who require regular transfusions. Beta-thalassemia is caused by a change in the beta-globin gene, which causes the body to produce reduced or no beta-globin. ZYNTEGLO is made specifically for each patient, using the patient’s own blood stem cells and adds functional copies of the beta-globin gene to your cells. This may allow you to produce sufficient hemoglobin to stop receiving regular transfusions.

Important Safety Information

The most common side effects of ZYNTEGLO on the day of treatment are: Increased heart rate and abdominal pain. The most common side effects of ZYNTEGLO following treatment for up to 6 months are: low level of platelets, which may reduce the ability of blood to clot and may cause bleeding, low level of white blood cells, which may make you more susceptible to infection, and pain in arms or legs. Call your healthcare provider right away if you have new or unusual bleeding which may include any of these signs or symptoms: severe headache, abnormal bruising, nose bleed, blood in your urine, stool, or vomit, coughing up blood, or unusual stomach or back pain.

What is ZYNTEGLO?

ZYNTEGLO is for patients with beta-thalassemia who require regular transfusions.

Site Map
Privacy Policy
Terms of Service
Cookie Notice
Unsubscribe

The information on this website does not take the place of discussions with a healthcare professional and is not intended to provide medical advice. If you are a patient or caregiver and have questions about ZYNTEGLO, ask your healthcare professional.

You are about to leave the ZYNTEGLO patient and caregiver website.

This link will take you to a website that is outside the control of bluebird bio, Inc. Links are provided for informational purposes only. We do not make or imply any endorsement of external websites.

Continue

Back
to Top

You have been unsubscribed

Unsubscribe successful.

We’re sorry to see you go. If you did this by mistake, or change your mind, please feel free to sign up again.

We’re sorry to see you go. If you did this by mistake, or change your mind,
please feel free to sign up again.